This study aims to create a reliable way to assess the neurological health of patients with leptomeningeal metastasis (cancer that has spread to the fluid and membranes surrounding the brain and spinal cord). Researchers will use a 'Neurological Assessment' where two different evaluators will check your neurological status. The main goal is to see how well these evaluators agree on their findings, which will help create a consistent scoring system for future use in both research and patient care. You may be able to join if you are an adult with a confirmed diagnosis of cancer outside the brain and spinal cord, and have leptomeningeal metastasis. The study is currently unclear on its recruitment status.

Study design

This is an observational study planning to enroll 200 participants. It does not involve a new drug or treatment.

What's involved

You will undergo a clinical neurological assessment performed by two different raters.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of the study is measured at December 2026, focusing on agreement between raters.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.